Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
DX

DXCM

Market Closed

DexCom, Inc.

NASDAQHealthcareMedical - Devices
US
11.05K employees
CEO: Jacob Steven Leach
Founded: 2005
$83.33
+$0.00(+NaN%)
Market Cap
31.08B
Beta
1.44
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: DexCom's current price exceeds all valuation models' midpoints, indicating overvaluation with 25.7% implied downside and 100% Monte Carlo downside risk below $81.67. Strong profitability and liquidity contrast with moderate growth (3/5), raising concerns about sustained expansion. High valuation volatility (36.19% coefficient of variation) suggests elevated investment risk.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore DXCM

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

DXCM in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Medical - Devices

Browse industry stocks →